Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Ito Y, Tamai S, Hoshino H, Okamoto N, Iimori K
Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
Cancer. 1993 Jul 15;72(2):369-74. doi: 10.1002/1097-0142(19930715)72:2<369::aid-cncr2820720210>3.0.co;2-5.
The relationship between the DNA synthetic activity of hepatocytes from cirrhotic liver tissue and the incidence of hepatocellular carcinoma (HCC) during a 3-year follow-up period was studied in male and female patients with posthepatitic cirrhosis.
The bromodeoxyuridine labeling index (BrdU LI) of hepatocytes was estimated in 38 cirrhotic patients (Child A stage, 23 men and 15 women) using a BrdU/anti-BrdU in vitro method. The incidence of HCC was compared between male and female cirrhotic patients during a 3-year follow-up period.
Sixteen of 23 (69.6%) male patients belonged to the high-DNA synthesis group (BrdU LI > or = 1.5%), and only 7 (30.4%) were in the low-DNA synthesis group (BrdU LI < 1.5%). Among female patients, only 5 of 15 (33.3%) were in the high-DNA synthesis group, and 10 of 15 (66.7%) were in the low-DNA synthesis group (P < 0.05). Eleven of 23 (47.8%) male patients and 3 of 15 (20.0%) female patients had HCC develop. In the high-DNA synthesis group, 10 of 16 (62.5%) of the men and 3 of 5 (60.0%) of the women had HCC develop during the follow-up period. In contrast, only one of seven (14.3%) male patients and none of ten (0%) female patients in the low-DNA synthesis group had HCC develop.
It was concluded that HCC developed frequently (about 60% of the time within 3 years) in patients of both sexes who were in a high-DNA synthesis group. Thus, the larger proportion of men in the high-DNA synthesis group compared with the number of women in the group (69.6% versus 33.3%) might be one possible reason for the male predominance in the development of HCC in cirrhotic patients.
在患有肝炎后肝硬化的男性和女性患者中,研究了肝硬化肝组织中肝细胞的DNA合成活性与3年随访期内肝细胞癌(HCC)发病率之间的关系。
采用体外BrdU/抗BrdU法,对38例肝硬化患者(Child A期,23例男性和15例女性)的肝细胞溴脱氧尿苷标记指数(BrdU LI)进行评估。比较男性和女性肝硬化患者在3年随访期内HCC的发病率。
23例男性患者中有16例(69.6%)属于高DNA合成组(BrdU LI≥1.5%),只有7例(30.4%)属于低DNA合成组(BrdU LI<1.5%)。在女性患者中,15例中只有5例(33.3%)属于高DNA合成组,15例中有10例(66.7%)属于低DNA合成组(P<0.05)。23例男性患者中有11例(47.8%)发生了HCC,15例女性患者中有3例(20.0%)发生了HCC。在高DNA合成组中,随访期间16例男性中有10例(62.5%)和5例女性中有3例(60.0%)发生了HCC。相比之下,低DNA合成组中7例男性患者中只有1例(14.3%)发生了HCC,10例女性患者中无一例(0%)发生HCC。
得出的结论是,高DNA合成组的男女患者中HCC的发生频率较高(3年内约60%的时间)。因此,高DNA合成组中男性比例高于女性(69.6%对33.3%)可能是肝硬化患者HCC发生中男性占主导地位的一个可能原因。